Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Osteosarcoma × camrelizumab × Clear all

Phase

Status

Unknown 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Advanced Gastric Cancer 2 Thoracic Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Osteosarcoma 1 Neoplasms by Site 1 Mouth Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Liver Diseases 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gestational Trophoblastic Disease 1 Gastrointestinal Neoplasms 1

Interventions

Ifosfamide 17 Methotrexate 16 Doxorubicin 14 Filgrastim 13 Etoposide 12 Cisplatin 12 Cyclophosphamide 10 Gemcitabine 9 Leucovorin 8 Sirolimus 6 Carboplatin 6 Topotecan 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Temozolomide 4 Sorafenib 4 Radiotherapy 4 Peripheral Blood Stem Cell Transplantation 4 Docetaxel 4 trimetrexate glucuronate 3 temsirolimus 3 dinutuximab 3 cixutumumab 3 apatinib 3 Vincristine 3 Specimen Handling 3 Oxaliplatin 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03359018 2020-05-19

APFAO

Peking University People's Hospital

Phase 2 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡